CHI3L1 and amyotrophic lateral sclerosis: YKL-40 can be detected in cerebrospinal fluid (CSF) and the levels are increased in preclinical and prodromal AD, as well as in other neurodegenerative conditions, such as Frontotemporal Lobar Degeneration (FTLD), Amyotrophic Lateral Sclerosis (ALS) or Multiple Sclerosis (MS)7–10.